Stuart Bryan 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 27, 2020
Insider Transaction Report
Form 4
Stuart Bryan
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2020-01-23+105,000→ 105,000 totalExercise: $16.87Exp: 2030-01-22→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service.